OCUL - Company ID 0001393434
OCULAR THERAPEUTIX, INC (OCUL) reported revenue of $51.95M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $51.95M | -18.5% |
| FY 2024 | $63.72M | +9.0% |
| FY 2023 | $58.44M | +13.5% |
| FY 2022 | $51.49M | +18.3% |
| FY 2021 | $43.52M | +150.1% |
| FY 2020 | $17.40M | +311.7% |
| FY 2019 | $4.23M | +112.4% |
| FY 2018 | $1.99M | +3.5% |
| FY 2017 |
OCULAR THERAPEUTIX, INC (OCUL) reported revenue of $51.95M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2012 and fiscal 2025, OCULAR THERAPEUTIX, INC's revenue grew from $10.00K to $51.95M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.92M |
| +1.9% |
| FY 2016 | $1.89M | +7.8% |
| FY 2015 | $1.75M | +126.7% |
| FY 2014 | $772.00K | +7620.0% |
| FY 2012 | $10.00K | - |